DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more
Drugs by Name Drugs by Condition Drugs by Category Most Searched Ratings/Reviews Active Ingred's Alerts Adverse Events

Mytelase (Ambenonium Chloride) - Summary

Mytelase Rx
Summary Description Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Clinical Pharmacology Other Rx Information Active Ingredients Adverse Event Reports
 

Mytelase News
News in Media Published Studies Curr't Clinical Trials


Nutrilib.com
A comprihensive source of nutritional information

MYTELASE SUMMARY

MYTELASE®
AMBENONIUM
CHLORIDE

MYTELASE, brand of ambenonium chloride, is [Oxalylbis (iminoethylene)] bis[(o -chlorobenzyl) diethylammonium] dichloride. The compound is a cholinesterase inhibitor with all the pharmacologic actions of acetylcholine, both the muscarinic and nicotinic types.

This drug is indicated for the treatment of myasthenia gravis.


See all Mytelase indications & dosage >>

MYTELASE NEWS HIGHLIGHTS

Media Articles Related to Mytelase (Ambenonium)

Myasthenia Gravis
Source: MedicineNet Electromyogram Specialty [2007.12.19]

more >>

Published Studies Related to Mytelase (Ambenonium)

Sensitive determination of ambenonium in plasma using inhibitory activity to acetylcholinesterase. [1993.03]

Influence of food on serum ambenonium concentration in patients with myasthenia gravis. [1992]

Pharmacokinetics of ambenonium chloride in dogs after intravenous and oral administration. [1989.02]

more >>
Page last updated: 2007-12-19

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008